Michael Gray - Net Worth and Insider Trading
Michael Gray Net Worth
The estimated net worth of Michael Gray is at least $553,764 dollars as of 2024-04-25. Michael Gray is the CFO of Curis Inc and owns about 21,461 shares of Curis Inc (CRIS) stock worth over $316,979. Michael Gray is also the CFO & COO of Imara Inc and owns about 37,466 shares of Imara Inc (IMRA) stock worth over $236,785. Details can be seen in Michael Gray's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael Gray has not made any transactions after 2023-01-30 and currently still holds the listed stock(s).
Transaction Summary of Michael Gray
Michael Gray Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Gray owns 6 companies in total, including Therapeutics Acquisition Corp (RACA) , Imara Inc (IMRA) , and X4 Pharmaceuticals Inc (XFOR) among others .
Click here to see the complete history of Michael Gray’s form 4 insider trades.
Insider Ownership Summary of Michael Gray
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RACA | Therapeutics Acquisition Corp | 2020-07-07 | director |
| IMRA | Imara Inc | 2023-01-30 | See Remarks |
| XFOR | X4 Pharmaceuticals Inc | 2017-11-15 | director & See Remarks |
| CRIS | Curis Inc | 2013-11-12 | Chief Financial Officer |
| PNT | POINT Biopharma Global Inc | 2020-07-07 | director |
| ELVN | Enliven Therapeutics Inc | 2020-03-11 | See Remarks |
Michael Gray Latest Holdings Summary
Michael Gray currently owns a total of 2 stocks. Among these stocks, Michael Gray owns 21,461 shares of Curis Inc (CRIS) as of November 12, 2013, with a value of $316,979 and a weighting of 57.24%. Michael Gray also owns 37,466 shares of Imara Inc (IMRA) as of January 30, 2023, with a value of $236,785 and a weighting of 42.76%.
Michael Gray Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Gray has made a total of 0 transactions in Curis Inc (CRIS) over the past 5 years. The most-recent trade in Curis Inc is the acquisition of 2,000 shares on November 12, 2013, which cost Michael Gray around $28,600.
According to the SEC Form 4 filings, Michael Gray has made a total of 2 transactions in Imara Inc (IMRA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Imara Inc is the sale of 3,596 shares on January 30, 2023, which brought Michael Gray around $14,096.
Insider Trading History of Michael Gray
- 1
Michael Gray Trading Performance
GuruFocus tracks the stock performance after each of Michael Gray's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Gray is 3.87%. GuruFocus also compares Michael Gray's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Gray within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Gray's insider trading performs compared to the benchmark.
Performance of Michael Gray
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -10.92 | 3.87 | -27.46 | -54.23 | -7.88 | 5.76 |
| Relative Return to S&P 500(%) | -11.36 | 0.95 | -34.76 | -69.54 | -15.46 | -1.22 |
Michael Gray Ownership Network
Ownership Network List of Michael Gray
Ownership Network Relation of Michael Gray
Michael Gray Owned Company Details
What does Therapeutics Acquisition Corp do?
Who are the key executives at Therapeutics Acquisition Corp?
Michael Gray is the director of Therapeutics Acquisition Corp. Other key executives at Therapeutics Acquisition Corp include director & Chief Executive Officer Peter Kolchinsky , 10 percent owner Therapeutics Acquisition Holdings Llc , and director & Chief Financial Officer Matthew Hammond .
Therapeutics Acquisition Corp (RACA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Therapeutics Acquisition Corp (RACA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Therapeutics Acquisition Corp (RACA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Therapeutics Acquisition Corp (RACA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Therapeutics Acquisition Corp Insider Transactions
Michael Gray Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Gray. You might contact Michael Gray via mailing address: C/o Curis Inc, 4 Maguire Road, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
